Skip to content

Clinical trials

Phase 2 Hodgkin Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 2 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20192
20201
20211
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status4
Completed2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University4
National Research Center for Hematology, Russia2
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Merck Sharp & Dohme LLC1
National Medical Research Radiological Centre of the Ministry of Health of Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease11
Recurrence3
Lymphoma1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.